Healthcare investment firm Patient Square Capital (Patient Square), has closed its inaugural fund with approximately $3.9bn in total capital commitments, surpassing its $3 billion target, which the firm says makes it the largest first-time private equity fund ever raised, and the largest fund ever raised by a dedicated health-care-focused private equity, growth equity, or venture capital firm.
Patient Square now has approximately $5.9 billion in total assets under management (AUM), including significant co-investment commitments from leading institutional investors.
Patient Square invests broadly across the health care industry, including development-stage therapeutics; commercial-stage pharmaceuticals; medical devices, diagnostics, and life science tools; health care providers; and technology-enabled and other services.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Since June 2021, Patient Square has deployed approximately $3 billion in equity capital, including significant co-investment commitments. The fund’s portfolio companies include Access Telecare, Apollo Therapeutics, Eargo, Enavate Sciences, Hanger Inc, Kriya Therapeutics, Radius Health, Resolve Biosciences, and Summit BHC.
Source: Private Equity Wire
Can’t stop reading? Read more
Blackstone taps bond market as private credit BDCs end issuance drought
Blackstone taps bond market as private credit BDCs end issuance drought Blackstone's private...
EQT raises the stakes with revised $12.3bn bid for Intertek
EQT raises the stakes with revised $12.3bn bid for Intertek EQT has tabled an improved takeover...
Temasek’s Azalea bets on evergreen structure to democratise private equity access
Temasek's Azalea bets on evergreen structure to democratise private equity access Azalea, a unit...